Search company, investor...


Acquired | Acquired

Total Raised


About Netpulse

Netpulse, headquartered in San Francisco, is the fitness industry's first and only enterprise-level platform for engaging consumers across multiple touch points, in and out of the club. Netpulse technology powers cardio equipment from leading equipment manufacturers, club-branded web and mobile applications, and integrates new technologies with club management systems and in-club digital experiences to deliver engagement, measurement, and monetization of members' fitness activity.

Headquarters Location

50 Osgood Place Floor 4

San Francisco, California, 94133,

United States




Research containing Netpulse

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Netpulse in 1 CB Insights research brief, most recently on Dec 9, 2021.

Expert Collections containing Netpulse

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Netpulse is included in 1 Expert Collection, including Ad Tech.


Ad Tech

3,757 items

Companies offering tech-enabled marketing and advertising services.

Latest Netpulse News

netpulse AG Unveils Revolutionary Online Marketing Solutions for the Digital Age

Feb 17, 2024

Share this news: netpulse AG excels in offering innovative online marketing solutions, including SEO, PPC, social media, and content strategy. Their data-driven approach boosts online presence, enhances engagement, and increases brand visibility, establishing them as a leading digital marketing partner for growth-oriented businesses. Winterthur, Switzerland - February 16, 2024 /PressCable/ — netpulse AG, a leader in digital marketing innovation, is proud to announce the launch of its comprehensive suite of online marketing solutions designed to propel businesses into a new era of digital excellence. With an unwavering commitment to driving growth and enhancing online visibility, netpulse AG introduces a range of services that include advanced SEO, precision-targeted PPC campaigns, dynamic social media strategies, and impactful content creation. In an ever-evolving digital landscape, staying ahead of marketing trends and technologies is paramount. netpulse AG leverages cutting-edge data analytics and creative approaches to ensure that each client's digital marketing strategy is both effective and tailored to their unique business needs. From increasing website traffic and improving search engine rankings to engaging audiences on social media platforms, netpulse AG's solutions are crafted to deliver measurable results and a significant return on investment. The digital marketing services offered by netpulse AG are designed to be comprehensive and versatile, catering to a wide range of industries and business sizes. Whether it's a startup looking to establish a digital footprint or a large corporation seeking to enhance its online presence, netpulse AG's solutions are scalable and customizable to meet any challenge. Key offerings include:

Netpulse Frequently Asked Questions (FAQ)

  • Where is Netpulse's headquarters?

    Netpulse's headquarters is located at 50 Osgood Place, San Francisco.

  • What is Netpulse's latest funding round?

    Netpulse's latest funding round is Acquired.

  • How much did Netpulse raise?

    Netpulse raised a total of $53.5M.

  • Who are the investors of Netpulse?

    Investors of Netpulse include EGYM, Frontier Venture Capital, Javelin Venture Partners, August Capital, NGP Capital and 4 more.

  • Who are Netpulse's competitors?

    Competitors of Netpulse include eSight, AlterG, Active Implants, Wright Medical Group, Ekso Bionics and 7 more.


Compare Netpulse to Competitors

Biophan Technologies

Biophan is dedicated to providing technologies that offer innovative andcompetitive advantages to the medical device industry. The Company ishelping to commercialize the Myotech Circulatory Support System, which has potential to improve the treatment of acute heart failure.Biophan Technologies, Inc. holds a 68% interest in Myotech. Biophan istraded on the OTC market under the symbol BIPH, and is also listed on theFrankfurt Stock Exchange under the symbol BTN.

Mercator MedSystems

Mercator MedSystems is a medical technology company that focuses on the treatment of peripheral artery disease. The company offers catheter-guided, microfluid injection systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel, providing efficient and targeted treatment for vascular diseases. The technology also finds application in the treatment of hypertension, oncology, and regenerative medicine. Mercator MedSystems was formerly known as EndoBionics. It was founded in 1999 and is based in Emeryville, California.


Audigence has developed patented software that better tunes cochlear implant and hearing aids for clearer speech recognition in hearing-impaired individuals.

Dornier MedTech Logo
Dornier MedTech

Dornier MedTech is a leading company in the urological medical device industry, focusing on the development and provision of innovative urology care solutions. The company offers a range of products including shock wave lithotripsy devices, laser systems, endoscopes, and urology workstations designed to treat various urological conditions in a clinical setting. Dornier MedTech also provides digital platforms to support patient care and community engagement in the field of urology. It is based in Kennesaw, Georgia.


Nephrologix Inc. is a private company that develops, manufactures and markets peritoneal dialysis (PD) systems.

TransCorp Logo

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.